 | • レポートコード：MRC2-11QY08362 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はオメプラゾールのグローバル市場について調査・分析したレポートです。種類別（カプセル、錠剤、注射）市場規模、用途別（子供、大人）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別オメプラゾールの競争状況、市場シェア ・世界のオメプラゾール市場：種類別市場規模 2015年-2020年（カプセル、錠剤、注射） ・世界のオメプラゾール市場：種類別市場規模予測 2021年-2026年（カプセル、錠剤、注射） ・世界のオメプラゾール市場：用途別市場規模 2015年-2020年（子供、大人） ・世界のオメプラゾール市場：用途別市場規模予測 2021年-2026年（子供、大人） ・北米のオメプラゾール市場分析：米国、カナダ ・ヨーロッパのオメプラゾール市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのオメプラゾール市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のオメプラゾール市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのオメプラゾール市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AstraZeneca AB、Sandoz、Actavis、Teva、Mylan、KernPharm、Garmish Pharmaceuticals、Sanofi, Mepha、Saval Pharmaceutical、Stada、Blaskov、CQ Lummy ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Omeprazole Market
The global Omeprazole market size is projected to reach US$ 2475 million by 2026, from US$ 2398.5 million in 2020, at a CAGR of 2.9%% during 2021-2026.
Global Omeprazole Scope and Market Size
Omeprazole market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Omeprazole market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Omeprazole market is segmented into
Capsule
Tablet
Injection
Segment by Application, the Omeprazole market is segmented into
Children
Adult
Regional and Country-level Analysis
The Omeprazole market is analysed and market size information is provided by regions (countries).
The key regions covered in the Omeprazole market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Omeprazole Market Share Analysis
Omeprazole market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Omeprazole business, the date to enter into the Omeprazole market, Omeprazole product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca AB
Sandoz
Actavis
Teva
Mylan
KernPharm
Garmish Pharmaceuticals
Sanofi, Mepha
Saval Pharmaceutical
Stada
Blaskov
CQ Lummy
1 Study Coverage
1.1 Omeprazole Product Introduction
1.2 Market Segments
1.3 Key Omeprazole Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Omeprazole Market Size Growth Rate by Type
1.4.2 Capsule
1.4.3 Tablet
1.4.4 Injection
1.5 Market by Application
1.5.1 Global Omeprazole Market Size Growth Rate by Application
1.5.2 Children
1.5.3 Adult
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Omeprazole Market Size, Estimates and Forecasts
2.1.1 Global Omeprazole Revenue 2015-2026
2.1.2 Global Omeprazole Sales 2015-2026
2.2 Global Omeprazole, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Omeprazole Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Omeprazole Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Omeprazole Competitor Landscape by Players
3.1 Omeprazole Sales by Manufacturers
3.1.1 Omeprazole Sales by Manufacturers (2015-2020)
3.1.2 Omeprazole Sales Market Share by Manufacturers (2015-2020)
3.2 Omeprazole Revenue by Manufacturers
3.2.1 Omeprazole Revenue by Manufacturers (2015-2020)
3.2.2 Omeprazole Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Omeprazole Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Omeprazole Revenue in 2019
3.2.5 Global Omeprazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Omeprazole Price by Manufacturers
3.4 Omeprazole Manufacturing Base Distribution, Product Types
3.4.1 Omeprazole Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Omeprazole Product Type
3.4.3 Date of International Manufacturers Enter into Omeprazole Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Omeprazole Market Size by Type (2015-2020)
4.1.1 Global Omeprazole Sales by Type (2015-2020)
4.1.2 Global Omeprazole Revenue by Type (2015-2020)
4.1.3 Omeprazole Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Omeprazole Market Size Forecast by Type (2021-2026)
4.2.1 Global Omeprazole Sales Forecast by Type (2021-2026)
4.2.2 Global Omeprazole Revenue Forecast by Type (2021-2026)
4.2.3 Omeprazole Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Omeprazole Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Omeprazole Market Size by Application (2015-2020)
5.1.1 Global Omeprazole Sales by Application (2015-2020)
5.1.2 Global Omeprazole Revenue by Application (2015-2020)
5.1.3 Omeprazole Price by Application (2015-2020)
5.2 Omeprazole Market Size Forecast by Application (2021-2026)
5.2.1 Global Omeprazole Sales Forecast by Application (2021-2026)
5.2.2 Global Omeprazole Revenue Forecast by Application (2021-2026)
5.2.3 Global Omeprazole Price Forecast by Application (2021-2026)
6 North America
6.1 North America Omeprazole by Country
6.1.1 North America Omeprazole Sales by Country
6.1.2 North America Omeprazole Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Omeprazole Market Facts & Figures by Type
6.3 North America Omeprazole Market Facts & Figures by Application
7 Europe
7.1 Europe Omeprazole by Country
7.1.1 Europe Omeprazole Sales by Country
7.1.2 Europe Omeprazole Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Omeprazole Market Facts & Figures by Type
7.3 Europe Omeprazole Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Omeprazole by Region
8.1.1 Asia Pacific Omeprazole Sales by Region
8.1.2 Asia Pacific Omeprazole Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Omeprazole Market Facts & Figures by Type
8.3 Asia Pacific Omeprazole Market Facts & Figures by Application
9 Latin America
9.1 Latin America Omeprazole by Country
9.1.1 Latin America Omeprazole Sales by Country
9.1.2 Latin America Omeprazole Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Omeprazole Market Facts & Figures by Type
9.3 Central & South America Omeprazole Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Omeprazole by Country
10.1.1 Middle East and Africa Omeprazole Sales by Country
10.1.2 Middle East and Africa Omeprazole Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Omeprazole Market Facts & Figures by Type
10.3 Middle East and Africa Omeprazole Market Facts & Figures by Application
11 Company Profiles
11.1 AstraZeneca AB
11.1.1 AstraZeneca AB Corporation Information
11.1.2 AstraZeneca AB Description and Business Overview
11.1.3 AstraZeneca AB Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca AB Omeprazole Products Offered
11.1.5 AstraZeneca AB Related Developments
11.2 Sandoz
11.2.1 Sandoz Corporation Information
11.2.2 Sandoz Description and Business Overview
11.2.3 Sandoz Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sandoz Omeprazole Products Offered
11.2.5 Sandoz Related Developments
11.3 Actavis
11.3.1 Actavis Corporation Information
11.3.2 Actavis Description and Business Overview
11.3.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Actavis Omeprazole Products Offered
11.3.5 Actavis Related Developments
11.4 Teva
11.4.1 Teva Corporation Information
11.4.2 Teva Description and Business Overview
11.4.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Teva Omeprazole Products Offered
11.4.5 Teva Related Developments
11.5 Mylan
11.5.1 Mylan Corporation Information
11.5.2 Mylan Description and Business Overview
11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mylan Omeprazole Products Offered
11.5.5 Mylan Related Developments
11.6 KernPharm
11.6.1 KernPharm Corporation Information
11.6.2 KernPharm Description and Business Overview
11.6.3 KernPharm Sales, Revenue and Gross Margin (2015-2020)
11.6.4 KernPharm Omeprazole Products Offered
11.6.5 KernPharm Related Developments
11.7 Garmish Pharmaceuticals
11.7.1 Garmish Pharmaceuticals Corporation Information
11.7.2 Garmish Pharmaceuticals Description and Business Overview
11.7.3 Garmish Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Garmish Pharmaceuticals Omeprazole Products Offered
11.7.5 Garmish Pharmaceuticals Related Developments
11.8 Sanofi, Mepha
11.8.1 Sanofi, Mepha Corporation Information
11.8.2 Sanofi, Mepha Description and Business Overview
11.8.3 Sanofi, Mepha Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sanofi, Mepha Omeprazole Products Offered
11.8.5 Sanofi, Mepha Related Developments
11.9 Saval Pharmaceutical
11.9.1 Saval Pharmaceutical Corporation Information
11.9.2 Saval Pharmaceutical Description and Business Overview
11.9.3 Saval Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Saval Pharmaceutical Omeprazole Products Offered
11.9.5 Saval Pharmaceutical Related Developments
11.10 Stada
11.10.1 Stada Corporation Information
11.10.2 Stada Description and Business Overview
11.10.3 Stada Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Stada Omeprazole Products Offered
11.10.5 Stada Related Developments
11.1 AstraZeneca AB
11.1.1 AstraZeneca AB Corporation Information
11.1.2 AstraZeneca AB Description and Business Overview
11.1.3 AstraZeneca AB Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca AB Omeprazole Products Offered
11.1.5 AstraZeneca AB Related Developments
11.12 CQ Lummy
11.12.1 CQ Lummy Corporation Information
11.12.2 CQ Lummy Description and Business Overview
11.12.3 CQ Lummy Sales, Revenue and Gross Margin (2015-2020)
11.12.4 CQ Lummy Products Offered
11.12.5 CQ Lummy Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Omeprazole Market Estimates and Projections by Region
12.1.1 Global Omeprazole Sales Forecast by Regions 2021-2026
12.1.2 Global Omeprazole Revenue Forecast by Regions 2021-2026
12.2 North America Omeprazole Market Size Forecast (2021-2026)
12.2.1 North America: Omeprazole Sales Forecast (2021-2026)
12.2.2 North America: Omeprazole Revenue Forecast (2021-2026)
12.2.3 North America: Omeprazole Market Size Forecast by Country (2021-2026)
12.3 Europe Omeprazole Market Size Forecast (2021-2026)
12.3.1 Europe: Omeprazole Sales Forecast (2021-2026)
12.3.2 Europe: Omeprazole Revenue Forecast (2021-2026)
12.3.3 Europe: Omeprazole Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Omeprazole Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Omeprazole Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Omeprazole Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Omeprazole Market Size Forecast by Region (2021-2026)
12.5 Latin America Omeprazole Market Size Forecast (2021-2026)
12.5.1 Latin America: Omeprazole Sales Forecast (2021-2026)
12.5.2 Latin America: Omeprazole Revenue Forecast (2021-2026)
12.5.3 Latin America: Omeprazole Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Omeprazole Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Omeprazole Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Omeprazole Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Omeprazole Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Omeprazole Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Omeprazole Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Omeprazole Market Segments
Table 2. Ranking of Global Top Omeprazole Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Omeprazole Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Capsule
Table 5. Major Manufacturers of Tablet
Table 6. Major Manufacturers of Injection
Table 7. Global Omeprazole Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Omeprazole Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Omeprazole Sales by Regions 2015-2020 (K MT)
Table 10. Global Omeprazole Sales Market Share by Regions (2015-2020)
Table 11. Global Omeprazole Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Omeprazole Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Omeprazole Sales Share by Manufacturers (2015-2020)
Table 14. Global Omeprazole Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Omeprazole by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Omeprazole as of 2019)
Table 16. Omeprazole Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Omeprazole Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Omeprazole Price (2015-2020) (USD/MT)
Table 19. Omeprazole Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Omeprazole Product Type
Table 21. Date of International Manufacturers Enter into Omeprazole Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Omeprazole Sales by Type (2015-2020) (K MT)
Table 24. Global Omeprazole Sales Share by Type (2015-2020)
Table 25. Global Omeprazole Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Omeprazole Revenue Share by Type (2015-2020)
Table 27. Omeprazole Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Omeprazole Sales by Application (2015-2020) (K MT)
Table 29. Global Omeprazole Sales Share by Application (2015-2020)
Table 30. North America Omeprazole Sales by Country (2015-2020) (K MT)
Table 31. North America Omeprazole Sales Market Share by Country (2015-2020)
Table 32. North America Omeprazole Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Omeprazole Revenue Market Share by Country (2015-2020)
Table 34. North America Omeprazole Sales by Type (2015-2020) (K MT)
Table 35. North America Omeprazole Sales Market Share by Type (2015-2020)
Table 36. North America Omeprazole Sales by Application (2015-2020) (K MT)
Table 37. North America Omeprazole Sales Market Share by Application (2015-2020)
Table 38. Europe Omeprazole Sales by Country (2015-2020) (K MT)
Table 39. Europe Omeprazole Sales Market Share by Country (2015-2020)
Table 40. Europe Omeprazole Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Omeprazole Revenue Market Share by Country (2015-2020)
Table 42. Europe Omeprazole Sales by Type (2015-2020) (K MT)
Table 43. Europe Omeprazole Sales Market Share by Type (2015-2020)
Table 44. Europe Omeprazole Sales by Application (2015-2020) (K MT)
Table 45. Europe Omeprazole Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Omeprazole Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Omeprazole Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Omeprazole Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Omeprazole Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Omeprazole Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Omeprazole Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Omeprazole Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Omeprazole Sales Market Share by Application (2015-2020)
Table 54. Latin America Omeprazole Sales by Country (2015-2020) (K MT)
Table 55. Latin America Omeprazole Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Omeprazole Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Omeprazole Revenue Market Share by Country (2015-2020)
Table 58. Latin America Omeprazole Sales by Type (2015-2020) (K MT)
Table 59. Latin America Omeprazole Sales Market Share by Type (2015-2020)
Table 60. Latin America Omeprazole Sales by Application (2015-2020) (K MT)
Table 61. Latin America Omeprazole Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Omeprazole Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Omeprazole Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Omeprazole Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Omeprazole Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Omeprazole Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Omeprazole Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Omeprazole Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Omeprazole Sales Market Share by Application (2015-2020)
Table 70. AstraZeneca AB Corporation Information
Table 71. AstraZeneca AB Description and Major Businesses
Table 72. AstraZeneca AB Omeprazole Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. AstraZeneca AB Product
Table 74. AstraZeneca AB Recent Development
Table 75. Sandoz Corporation Information
Table 76. Sandoz Description and Major Businesses
Table 77. Sandoz Omeprazole Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Sandoz Product
Table 79. Sandoz Recent Development
Table 80. Actavis Corporation Information
Table 81. Actavis Description and Major Businesses
Table 82. Actavis Omeprazole Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Actavis Product
Table 84. Actavis Recent Development
Table 85. Teva Corporation Information
Table 86. Teva Description and Major Businesses
Table 87. Teva Omeprazole Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Teva Product
Table 89. Teva Recent Development
Table 90. Mylan Corporation Information
Table 91. Mylan Description and Major Businesses
Table 92. Mylan Omeprazole Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Mylan Product
Table 94. Mylan Recent Development
Table 95. KernPharm Corporation Information
Table 96. KernPharm Description and Major Businesses
Table 97. KernPharm Omeprazole Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. KernPharm Product
Table 99. KernPharm Recent Development
Table 100. Garmish Pharmaceuticals Corporation Information
Table 101. Garmish Pharmaceuticals Description and Major Businesses
Table 102. Garmish Pharmaceuticals Omeprazole Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Garmish Pharmaceuticals Product
Table 104. Garmish Pharmaceuticals Recent Development
Table 105. Sanofi, Mepha Corporation Information
Table 106. Sanofi, Mepha Description and Major Businesses
Table 107. Sanofi, Mepha Omeprazole Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Sanofi, Mepha Product
Table 109. Sanofi, Mepha Recent Development
Table 110. Saval Pharmaceutical Corporation Information
Table 111. Saval Pharmaceutical Description and Major Businesses
Table 112. Saval Pharmaceutical Omeprazole Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Saval Pharmaceutical Product
Table 114. Saval Pharmaceutical Recent Development
Table 115. Stada Corporation Information
Table 116. Stada Description and Major Businesses
Table 117. Stada Omeprazole Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Stada Product
Table 119. Stada Recent Development
Table 120. Blaskov Corporation Information
Table 121. Blaskov Description and Major Businesses
Table 122. Blaskov Omeprazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Blaskov Product
Table 124. Blaskov Recent Development
Table 125. CQ Lummy Corporation Information
Table 126. CQ Lummy Description and Major Businesses
Table 127. CQ Lummy Omeprazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. CQ Lummy Product
Table 129. CQ Lummy Recent Development
Table 130. Global Omeprazole Sales Forecast by Regions (2021-2026) (K MT)
Table 131. Global Omeprazole Sales Market Share Forecast by Regions (2021-2026)
Table 132. Global Omeprazole Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 133. Global Omeprazole Revenue Market Share Forecast by Regions (2021-2026)
Table 134. North America: Omeprazole Sales Forecast by Country (2021-2026) (K MT)
Table 135. North America: Omeprazole Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Europe: Omeprazole Sales Forecast by Country (2021-2026) (K MT)
Table 137. Europe: Omeprazole Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Asia Pacific: Omeprazole Sales Forecast by Region (2021-2026) (K MT)
Table 139. Asia Pacific: Omeprazole Revenue Forecast by Region (2021-2026) (US$ Million)
Table 140. Latin America: Omeprazole Sales Forecast by Country (2021-2026) (K MT)
Table 141. Latin America: Omeprazole Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Middle East and Africa: Omeprazole Sales Forecast by Country (2021-2026) (K MT)
Table 143. Middle East and Africa: Omeprazole Revenue Forecast by Country (2021-2026) (US$ Million)
Table 144. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 145. Key Challenges
Table 146. Market Risks
Table 147. Main Points Interviewed from Key Omeprazole Players
Table 148. Omeprazole Customers List
Table 149. Omeprazole Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Omeprazole Product Picture
Figure 2. Global Omeprazole Sales Market Share by Type in 2020 & 2026
Figure 3. Capsule Product Picture
Figure 4. Tablet Product Picture
Figure 5. Injection Product Picture
Figure 6. Global Omeprazole Sales Market Share by Application in 2020 & 2026
Figure 7. Children
Figure 8. Adult
Figure 9. Omeprazole Report Years Considered
Figure 10. Global Omeprazole Market Size 2015-2026 (US$ Million)
Figure 11. Global Omeprazole Sales 2015-2026 (K MT)
Figure 12. Global Omeprazole Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Omeprazole Sales Market Share by Region (2015-2020)
Figure 14. Global Omeprazole Sales Market Share by Region in 2019
Figure 15. Global Omeprazole Revenue Market Share by Region (2015-2020)
Figure 16. Global Omeprazole Revenue Market Share by Region in 2019
Figure 17. Global Omeprazole Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Omeprazole Revenue in 2019
Figure 19. Omeprazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Omeprazole Sales Market Share by Type (2015-2020)
Figure 21. Global Omeprazole Sales Market Share by Type in 2019
Figure 22. Global Omeprazole Revenue Market Share by Type (2015-2020)
Figure 23. Global Omeprazole Revenue Market Share by Type in 2019
Figure 24. Global Omeprazole Market Share by Price Range (2015-2020)
Figure 25. Global Omeprazole Sales Market Share by Application (2015-2020)
Figure 26. Global Omeprazole Sales Market Share by Application in 2019
Figure 27. Global Omeprazole Revenue Market Share by Application (2015-2020)
Figure 28. Global Omeprazole Revenue Market Share by Application in 2019
Figure 29. North America Omeprazole Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Omeprazole Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Omeprazole Sales Market Share by Country in 2019
Figure 32. North America Omeprazole Revenue Market Share by Country in 2019
Figure 33. U.S. Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Omeprazole Market Share by Type in 2019
Figure 38. North America Omeprazole Market Share by Application in 2019
Figure 39. Europe Omeprazole Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Omeprazole Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Omeprazole Sales Market Share by Country in 2019
Figure 42. Europe Omeprazole Revenue Market Share by Country in 2019
Figure 43. Germany Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Omeprazole Market Share by Type in 2019
Figure 54. Europe Omeprazole Market Share by Application in 2019
Figure 55. Asia Pacific Omeprazole Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Omeprazole Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Omeprazole Sales Market Share by Region in 2019
Figure 58. Asia Pacific Omeprazole Revenue Market Share by Region in 2019
Figure 59. China Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Omeprazole Market Share by Type in 2019
Figure 82. Asia Pacific Omeprazole Market Share by Application in 2019
Figure 83. Latin America Omeprazole Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Omeprazole Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Omeprazole Sales Market Share by Country in 2019
Figure 86. Latin America Omeprazole Revenue Market Share by Country in 2019
Figure 87. Mexico Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Omeprazole Market Share by Type in 2019
Figure 94. Latin America Omeprazole Market Share by Application in 2019
Figure 95. Middle East and Africa Omeprazole Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Omeprazole Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Omeprazole Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Omeprazole Revenue Market Share by Country in 2019
Figure 99. Turkey Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Omeprazole Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Omeprazole Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Omeprazole Market Share by Type in 2019
Figure 106. Middle East and Africa Omeprazole Market Share by Application in 2019
Figure 107. North America Omeprazole Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 108. North America Omeprazole Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Omeprazole Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. Europe Omeprazole Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Omeprazole Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Asia Pacific Omeprazole Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Omeprazole Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Latin America Omeprazole Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Omeprazole Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Middle East and Africa Omeprazole Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
アダルトストアの世界市場（～2026年） Adult Stores sell various products such as couples toys, bullet vibrators, condoms, personal lubricants, erotic lingerie, and sexual enhancement supplements People around the globe, particularly in countries in the Americas and EMEA, are coming out to identify themselves as a part of the lesbian, ga…- タブレット＆ペレットコーティングシステムの世界市場（～2026年） Tablet & pellets coating is among the traditional pharmaceutical processes which is still continuing with advanced machinery technologies. The major factors boosting the growth of tablet & pellet coating systems market are pharmaceutical industry growth, advancement in tablet coating market, increas…
- 成人用悪性神経膠腫治療薬の世界市場（～2026年） Glioblastoma multiforme (GBM) is among the most difficult of tumors to treat, and despite all efforts, median overall survival remains at approximately 12 months. Malignant gliomas are included in the category of rare diseases, and the orphan drug status is granted for the drug candidates in the pip…
- ノートパソコン・タブレットPCの世界市場（～2026年） A tablet computer, commonly shortened to tablet, is a mobile device, typically with a mobile operating system and LCD touchscreen display processing circuitry, and a rechargeable battery in a single thin, flat package and a laptop, also called a notebook computer or simply a notebook, is a small, po…
- 内部鎮痛剤錠剤の世界市場（～2026年） Market Analysis and Insights: Global Internal Analgesic Tablet Market The global Internal Analgesic Tablet market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Internal Analgesic Tablet Scope and Market Size Internal Analge…